Affiliation: City of Hope

Dr. Naseeb Kaur Malhi received her BMedSc from the University of Birmingham, UK in 2014 where she conducted research focused on angiogenesis and tumour endothelial marker CLEC14A. After a stint as a research scientist at immunodiagnostic company, The Binding Site, she undertook a PhD at the University of Nottingham, UK determining the impact of targeting alternative splicing on vascular permeability in diabetic retinopathy. Currently, she is a postdoctoral researcher in the lab of Dr. Zhen Bouman Chen in the Department of Diabetes Complications and Metabolism at City of Hope, California where her research focuses on elucidating endothelial function and dysfunction in diabetes-related conditions